Biomedica Foscama is a long established Italian pharmaceutical company since 1947.

It is an international company supplying more than 15 markets worldwide (including CIS, China and Far East countries). It is a flexible company ready to adapt its production capacity to the market and to the customers’ needs.


Foundation of the company from the union of Biomedica International and Foscama


Launch in Italy of Hexaphosphine (fructose-1,6-diphosphate)


Launch of TAD (glutathione) in Italy

October 2019

Acquisition by auction of the site from SPL

November 2019

Complete revamping to reactivate the site

July 2020 GMP

certificate for finished dosage form

August 2020

GMP certificate for API


New injectable vials area with tunnel, autoclave for terminal sterilization.


New freeze-drying area to increase current production capacity


New area dedicated to vaccines and high containment products

Our strengths:

Vertical integration

Biomedica Foscama is able to sustain the entire value chain: from raw material to finished product.

Flexibility and ability to expand capacity in a modular way

Biomedica Foscama is able to meet specific needs thanks to dynamism, reliability and production modularity.

Ahead of changes

Thanks to its long-term entrepreneurial vision, Biomedica Foscama anticipates changes in the industry and invests in cutting-edge solutions, also looking at new markets.

Problem solving

Biomedica Foscama boasts true operational excellence and pursues a company policy aimed at continuous and ambitious improvement.

Biomedica Foscama

The ideal partner for the development and manufacturing of sterile products

Do you want to be our partner?
Contact us